Arecor Therapeutics plc
AREC.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £24,578 | £55,886 | £69,447 | £92,134 |
| - Cash | £3,239 | £5,093 | £4,765 | £18,316 |
| + Debt | £232 | £338 | £288 | £231 |
| Enterprise Value | £21,571 | £51,131 | £64,970 | £74,049 |
| Revenue | £5,053 | £4,573 | £2,403 | £1,158 |
| % Growth | 10.5% | 90.3% | 107.5% | – |
| Gross Profit | £1,543 | £4,573 | £2,403 | £1,158 |
| % Margin | 30.5% | 100% | 100% | 100% |
| EBITDA | -£10,150 | -£8,390 | -£10,062 | -£6,267 |
| % Margin | -200.9% | -183.5% | -418.7% | -541.2% |
| Net Income | -£10,236 | -£8,554 | -£9,260 | -£6,169 |
| % Margin | -202.6% | -187.1% | -385.4% | -532.7% |
| EPS Diluted | -0.31 | -0.28 | -0.32 | -0.27 |
| % Growth | -10.7% | 12.5% | -18.5% | – |
| Operating Cash Flow | -£9,155 | -£5,841 | -£10,780 | -£5,450 |
| Capital Expenditures | -£23 | -£151 | -£345 | -£69 |
| Free Cash Flow | -£9,178 | -£5,992 | -£11,125 | -£5,519 |